(ETG) EnviTec Biogas - Ratings and Ratios
Biogas, Biomethane, Electricity, Heat, Gas
ETG EPS (Earnings per Share)
ETG Revenue
Description: ETG EnviTec Biogas
EnviTec Biogas AG is a leading operator in the biogas and biomethane industry, with a global presence across multiple countries including Germany, Italy, and the United States. The company operates through three main segments: Own Plant operation, Service, and Plant Construction, providing a comprehensive range of services from planning and construction to management and maintenance of biogas plants.
The companys business model is diversified, generating revenue from the sale of electricity, heat, and gas produced by its own biogas plants, as well as from construction and service contracts. With a strong foundation in the renewable energy sector, EnviTec Biogas AG is well-positioned to capitalize on the growing demand for clean energy solutions. Key Performance Indicators (KPIs) such as revenue growth, EBITDA margin, and return on equity (RoE) of 16.50% indicate a robust financial performance.
From a valuation perspective, the companys Price-to-Earnings (P/E) ratio of 2.60 suggests a relatively low valuation compared to its earnings, potentially indicating undervaluation. To further assess the companys attractiveness, additional KPIs such as Debt-to-Equity ratio, Interest Coverage ratio, and Operating Cash Flow margin could be examined. A deeper dive into the companys financials and industry trends would be necessary to determine the sustainability of its growth and profitability.
EnviTec Biogas AGs commitment to renewable energy and its diversified business model make it an interesting investment opportunity in the Renewable Electricity sub-industry. With a market capitalization of 380.16M EUR, the company has a significant presence in the European market, and its expansion into international markets could provide further growth opportunities.
ETG Stock Overview
| Market Cap in USD | 334m |
| Sub-Industry | Renewable Electricity |
| IPO / Inception |
ETG Stock Ratings
| Growth Rating | -12.0% |
| Fundamental | 47.5% |
| Dividend Rating | 40.6% |
| Return 12m vs S&P 500 | -46.4% |
| Analyst Rating | - |
ETG Dividends
| Dividend Yield 12m | 2.05% |
| Yield on Cost 5y | 3.53% |
| Annual Growth 5y | 24.57% |
| Payout Consistency | 62.4% |
| Payout Ratio | 30.4% |
ETG Growth Ratios
| Growth Correlation 3m | -84.4% |
| Growth Correlation 12m | -57.2% |
| Growth Correlation 5y | 28.3% |
| CAGR 5y | 6.04% |
| CAGR/Max DD 5y | 0.09 |
| Sharpe Ratio 12m | -0.09 |
| Alpha | -47.35 |
| Beta | 0.272 |
| Volatility | 58.40% |
| Current Volume | 0.2k |
| Average Volume 20d | 1.9k |
| Stop Loss | 17.8 (-6.6%) |
| Signal | 1.82 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (28.6m TTM) > 0 and > 6% of Revenue (6% = 21.7m TTM) |
| FCFTA -0.16 (>2.0%) and ΔFCFTA -19.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 28.04% (prev 27.89%; Δ 0.15pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.03 (>3.0%) and CFO -10.4m <= Net Income 28.6m (YES >=105%, WARN >=100%) |
| Net Debt (94.1m) to EBITDA (82.1m) ratio: 1.15 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.95 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (14.8m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 35.73% (prev 38.50%; Δ -2.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 86.96% (prev 121.6%; Δ -34.60pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.93 (EBITDA TTM 82.1m / Interest Expense TTM 3.31m) >= 6 (WARN >= 3) |
Altman Z'' 4.53
| (A) 0.24 = (Total Current Assets 207.8m - Total Current Liabilities 106.4m) / Total Assets 413.8m |
| (B) 0.38 = Retained Earnings (Balance) 156.4m / Total Assets 413.8m |
| (C) 0.14 = EBIT TTM 56.1m / Avg Total Assets 415.6m |
| (D) 0.75 = Book Value of Equity 171.4m / Total Liabilities 229.4m |
| Total Rating: 4.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.49
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield -17.01% = -5.0 |
| 3. FCF Margin -17.93% = -6.72 |
| 4. Debt/Equity 0.68 = 2.27 |
| 5. Debt/Ebitda 1.47 = 1.01 |
| 6. ROIC - WACC 8.30% = 10.37 |
| 7. RoE 16.50% = 1.37 |
| 8. Rev. Trend -28.39% = -1.42 |
| 9. Rev. CAGR 4.81% = 0.60 |
| 10. EPS Trend -60.08% = -1.50 |
| 11. EPS CAGR -31.60% = -2.50 |
What is the price of ETG shares?
Over the past week, the price has changed by -5.22%, over one month by -4.75%, over three months by -29.11% and over the past year by -37.34%.
Is EnviTec Biogas a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ETG is around 15.92 EUR . This means that ETG is currently overvalued and has a potential downside of -16.43%.
Is ETG a buy, sell or hold?
What are the forecasts/targets for the ETG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 17.3 | -9.3% |
ETG Fundamental Data Overview
Market Cap EUR = 286.6m (286.6m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 26.6m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 1.9574
P/S = 0.7931
P/B = 1.7166
Beta = 0.529
Revenue TTM = 361.4m EUR
EBIT TTM = 56.1m EUR
EBITDA TTM = 82.1m EUR
Long Term Debt = 71.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 49.4m EUR (from shortTermDebt, last quarter)
Debt = 120.7m EUR (Calculated: Short Term 49.4m + Long Term 71.4m)
Net Debt = 94.1m EUR (from netDebt column, last quarter)
Enterprise Value = 380.7m EUR (286.6m + Debt 120.7m - CCE 26.6m)
Interest Coverage Ratio = 16.93 (Ebit TTM 56.1m / Interest Expense TTM 3.31m)
FCF Yield = -17.01% (FCF TTM -64.8m / Enterprise Value 380.7m)
FCF Margin = -17.93% (FCF TTM -64.8m / Revenue TTM 361.4m)
Net Margin = 7.92% (Net Income TTM 28.6m / Revenue TTM 361.4m)
Gross Margin = 35.73% ((Revenue TTM 361.4m - Cost of Revenue TTM 232.2m) / Revenue TTM)
Tobins Q-Ratio = 2.22 (Enterprise Value 380.7m / Book Value Of Equity 171.4m)
Interest Expense / Debt = 2.75% (Interest Expense 3.31m / Debt 120.7m)
Taxrate = 31.85% (from yearly Income Tax Expense: 14.0m / 44.0m)
NOPAT = 38.2m (EBIT 56.1m * (1 - 31.85%))
Current Ratio = 1.95 (Total Current Assets 207.8m / Total Current Liabilities 106.4m)
Debt / Equity = 0.68 (Debt 120.7m / last Quarter total Stockholder Equity 176.5m)
Debt / EBITDA = 1.47 (Net Debt 94.1m / EBITDA 82.1m)
Debt / FCF = -1.86 (Debt 120.7m / FCF TTM -64.8m)
Total Stockholder Equity = 173.6m (last 4 quarters mean)
RoA = 6.92% (Net Income 28.6m, Total Assets 413.8m )
RoE = 16.50% (Net Income TTM 28.6m / Total Stockholder Equity 173.6m)
RoCE = 22.91% (Ebit 56.1m / (Equity 173.6m + L.T.Debt 71.4m))
RoIC = 13.79% (NOPAT 38.2m / Invested Capital 277.3m)
WACC = 5.49% (E(286.6m)/V(407.3m) * Re(7.02%)) + (D(120.7m)/V(407.3m) * Rd(2.75%) * (1-Tc(0.32)))
Shares Correlation 5-Years: 0.0 | Cagr: 0.0%
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -64.8m)
Revenue Correlation: -28.39 | Revenue CAGR: 4.81%
Rev Growth-of-Growth: -34.03
EPS Correlation: -60.08 | EPS CAGR: -31.60%
EPS Growth-of-Growth: -116.5